You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oral cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Melbourne (Talazoparib)

Recruiting
  • Neuroendocrine Tumors
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 20, 2021

Cancer, Older Adults Trial (Self-reported online geriatric assessment (CHAMP))

Not yet recruiting
  • Cancer
  • Older Adults
  • Self-reported online geriatric assessment (CHAMP)
  • (no location specified)
Aug 12, 2022

Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

Active, not recruiting
  • Gastrointestinal Cancer
  • New York, New York
  • +1 more
Nov 29, 2022

Rectal Tumor Malignant Trial in GuangZhou (TME+LLND, TME+nCRT)

Recruiting
  • Rectal Neoplasm Malignant
  • TME+LLND
  • TME+nCRT
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Nov 22, 2022

Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

Not yet recruiting
  • Cervical Cancer
  • Cervical Carcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Cetntre
Apr 9, 2023

Cancer in Patients at High Risk of Lung Cancer

Recruiting
  • Lung Cancer
  • comparative genomic hybridization
  • +10 more
  • Nashville, Tennessee
  • +1 more
May 17, 2022

Tumor and Peripheral Blood to Evaluate Efficacy of Cancer

Recruiting
  • Lung Cancer
  • Esophageal Cancer
  • In vitro stimulation of Pbmc with tumor antigen nanoparticles
  • Suzhou, Jiangsu, China
    The first affiliated hospital of soochow university
Mar 16, 2023

Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 11, 2023

Hepatocellular Carcinoma, Cholangiocarcinoma, Gastric Cancer Trial in Guangzhou (ZSP1241)

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 20, 2020

Colorectal Cancer Trial in Chongqing (Integrative omics)

Recruiting
  • Colorectal Cancer
  • Integrative omics
  • Chongqing, China
    Daping hospital
Jul 29, 2022

Complicated Appendicitis Trial in Slagelse (Antibiotic)

Recruiting
  • Complicated Appendicitis
  • Slagelse, Denmark
  • +1 more
Jul 13, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Transcatheter arterial chemoembolization
  • +3 more
  • (no location specified)
Feb 17, 2022

Cancer Trial in London (Integrated Short-term Palliative Rehabilitation)

Not yet recruiting
  • Cancer
  • Integrated Short-term Palliative Rehabilitation
  • London, United Kingdom
    Cicely Saunders Institute of Palliative Care, Policy & Rehabilit
Aug 2, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
  • Venetoclax-Decitabine/Azacitidine Association
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022

Couple-Based Mindfulness Intervention for Metastatic Colorectal

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Qualitative interview
  • Cognitive Interviews
  • Aurora, Colorado
    University of Colorado Cancer Center
Apr 21, 2023

Healthy, Skin Manifestations Trial in Stockholm (Probiotic with niacin and berry extract, Probiotic without niacin and berry

Active, not recruiting
  • Healthy
  • Skin Manifestations
  • Probiotic with niacin and berry extract
  • +2 more
  • Stockholm, Sweden
    Oriflame Cosmetics
Oct 26, 2022

Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

Active, not recruiting
Has Results
  • Metastatic Non-small Cell Lung Cancer
  • Metastatic Triple-negative Breast Cancer
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Cancer Center
Dec 28, 2022

Health Care Survey Trial in Munich (Survey)

Recruiting
  • Health Care Survey
  • Survey
  • Munich, Germany
    Klinikum rechts der Isar, Frauenklinik, Technische Universität M
Oct 28, 2022

Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte (Quality-of-Life

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +21 more
  • Quality-of-Life Assessment
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2022

Ovarian Cancer Metastatic Trial in Birmingham, Manchester (cyclophosphamide, fludarabine, IL-2 (Proleukin))

Withdrawn
  • Ovarian Cancer Metastatic
  • Birmingham, United Kingdom
  • +1 more
Dec 11, 2020

Obesity Trial in Lincoln (NO-13065, Placebo)

Active, not recruiting
  • Obesity
  • Lincoln, Nebraska
    Celerion
Apr 19, 2022

Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 5, 2023

Brain and CNS Tumors, Cognitive/Functional Effects, Fatigue Trial in Los Angeles (modafinil)

Completed
  • Brain and Central Nervous System Tumors
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

Recruiting
  • Colo-rectal Cancer
  • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
  • Beijing, China/Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023